We followed the course of canine parvovirus (CPV) antibody prevalence in a subpopulation of wolves (Canis lupus) in northeastern Minnesota from 1973, when antibodies were first detected, through 2004. Annual early pup survival was reduced by 70%, and wolf population change was related to CPV antibody prevalence. In the greater Minnesota population of 3,000 wolves, pup survival was reduced by 40-60%. This reduction limited the Minnesota wolf population rate of increase to about 4% per year compared with increases of 16-58% in other populations. Because it is young wolves that disperse, reduced pup survival may have caused reduced dispersal and reduced recolonization of new range in Minnesota.
INTRODUCTION
Canine parvovirus (CPV) may have originated from a feline panleukopenialike virus in a wild carnivore (Steinel et al., 2001) . The earliest evidence of CPV infection in a canine species comes from the detection of CPV antibodies in wild wolves (Canis lupus) that were sampled in northeastern Minnesota during 1973 (Mech and Goyal, 1995) . Antibodies to CPV subsequently were detected in domestic dogs (Canis lupus familiaris) in Greece in 1974 (Koptopoulos et al., 1986) and from dogs in the Netherlands in 1976 (Schwers et al., 1979) . The virus has been detected in wild and domestic canids worldwide (Steinel et al., 2001) .
Mortality related to CPV in domestic canids primarily is associated with younger animals (1-12 wk old; Eugster and Nairn, 1977; Meunier et al., 1981) , but almost nothing is known about the epidemiology of CPV in wild canid populations or its potential to impact populations negatively. The disease can be fatal to wolves (Mech et al., 1986; 1997) and is suspected to have caused declines or attenuation of wolf populations in Wisconsin (Wydeven et al., 1995) and on Isle Royale, Michigan (Peterson et al., 1998) . In a small area (2%) of Minnesota's wolf range, wolf population changes were highly related (r 2 50.83) to CPV antibody prevalence from 1984 through 1993 (Mech and Goyal, 1995) . Now, after following the course of CPV infection in wolves in that study area (intensive study area [ISA] ; 48uN latitude and 91u159W longitude) since the first appearance of CPV some 30 yr ago, we document its long-term effect in the ISA and demonstrate its effect on the entire Minnesota wolf population of some 3,000 animals over an 88,325-km 2 range. Our data consist of the following: 1) an annual antibody prevalence of CPV in wolves in our ISA from 1973 through 2004, 2) an index of annual wolf pup survival to 4 mo of age in the ISA, 3) an annual winter census of wolves in the ISA from 1972 through 2004, 4) intermittent CPV antibody prevalence estimates in wolves in the total Minnesota wolf range from 1979 to 2004, 5) an index of annual pup survival to 4 mo in the entire Minnesota wolf range from 1979 to 2004, and 6) histories of CPV antibody status in wolves sampled multiple times in the ISA.
MATERIALS AND METHODS

Study area
The ISA is a 2,060-km 2 part of the Superior National Forest northeast of Ely, Minnesota (Fig. 1) . The wolf population on the ISA is part of the much larger Minnesota wolf population that represents the southernmost extension of the Canadian wolf population, and has never been exterminated. Humans and dogs inhabit the western and southern edges of the ISA, and the entire area is used for recreation. The wolves feed primarily on white-tailed deer (Odocoileus virginianus), moose (Alces alces), and beavers (Castor canadensis). The Minnesota wolf range (Fig. 1) occupies the northeastern 40% of Minnesota, including wilderness and semiwilderness forest interspersed with farms, towns, and cities. Dispersing and nomadic wolves travel throughout this range and into neighboring Ontario, Manitoba, Wisconsin, and Michigan.
Wolf demography
We live-trapped wolves (Mech, 1974 ) from May to October or November in the ISA and the immediately adjacent area. In the greater Minnesota wolf range, we trapped and euthanized wolves as part of a government depredation-control program. We distinguished wolf pups from adults by the presence of milk canine teeth (Van Ballenberghe and Mech, 1975) . We also attached radio collars to most of the wolves captured in the ISA (Mech, 1974) and later located them from a fixed-wing FIGURE 1. The study areas. Minnesota wolf range is lined. The intensive study area (ISA) is black, and the Superior National Forest is gray.
aircraft. We aerially observed radio-tagged wolves and their packmates throughout each winter and counted all members of each pack in the census area. Numbers presented here represent the maximum observed members per radioed pack during December-January each year supplemented by tracks or observations of nonradioed packs whose territories fell wholly or partly in the census area (Mech, 1986) . Annual changes in estimated populations were related to annual changes in mean size of radioed packs (r 2 50.35; P,0.01), which were error-free knowns. We were able to obtain some information on pup litter size in our ISA by aerially observing radioed wolves with pups near their dens in late spring and summer. Because of poor visibility, these counts only represented minimum pup numbers.
Serology
We weighed, examined, and sexed each wolf caught and collected blood, which was processed for CPV antibodies as described below. We removed serum from blood samples and stored it at 215 C to 220 C until assaying for CPV antibody by the hemagglutination inhibition (HI) test (Carmichael et al., 1980) . Sera were heat activated, treated with 25% kaolin, and absorbed with packed porcine erythrocytes to remove nonspecific hemagglutinins. We mixed serial twofold dilutions of sera in 96-well microtiter plates with eight hemagglutination units of CPV and incubated them at 4 C overnight. A 1% suspension of porcine erythrocytes was added, and after 2 hr of incubation at 4 C the test was read. Antibody titer represented the reciprocal of highest serum dilution that completely inhibited hemagglutination; titers of $256 were considered positive. The HI test has not been validated in wolves and the CPV strain used in the test was derived from dogs; it is not known how close that strain is to CPV strains infecting wolves. Our positive threshold titer of $256 was conservative; titers of 128 are considered positive for CPV antibodies in dogs (Carmichael and Binn, 1981) . We considered the percentage of wolves that were positive on their first capture as the antibody prevalence for that year Mech et al., 1986) . Data from recaptured and retested wolves were counted in our antibody prevalence analyses only during the wolves' first year of capture and testing.
Simple linear and polynomial regression were used to relate trends in antibody prevalence with year, percent of pups caught, and percent annual changes in the wolf population, and chi-square tests were used to compare antibody prevalence among ages, sex, study areas, and years. Changes in CPV antibody prevalence were monitored over time for periodicity by comparing nine models under an information-theoretic model selection approach (Burnham and Anderson, 2002) . We posed a set of nine plausible models to describe the observed trajectory of CPV antibody prevalence in the ISA (Table 1) . Model 1 (Table 1) is a simple linear regression, model 2 is a quadratic regression, model 3 is a logistic growth model, and models 4-9 are combined logistic growth models with various trigonometric transformations with parameter P an estimate of period (Graybill, 1976) . We used the PROC NLIN of SAS (SAS Institute Inc., 2004) to fit all models with the default Gauss-Newton iterative method to compute parameter estimates. Akaike's information criteria for small samples (AIC c ) was used to determine which models best described the trajectory. This modeling effort is descriptive only, with no implications beyond the years of this study or to other wolf populations. Our goal was to determine how much evidence there is for periodicity in the nonlinear, increasing seroprevalence trajectory.
RESULTS
Intensive study area
Wolves were live-trapped (Mech, 1974) and bled (n5542 wolves) in the ISA area year-1972) . The number of parameters (k) includes one for the residual variance parameter s 2 (p53.14).
from 1972 through 2004. Some of the wolves were captured multiple times, and hence 720 samples were tested for CPV antibody (Mech and Goyal, 1995) . From 1973 From through 2004 wolves (total5518) were serologically tested per year during their first capture (Table 2) . We recaptured and CPV-tested 54 females and 44 males two-nine times each over intervals of 2 days to 5.9 yr, for a total of 175 capture/recapture pairs. Of those, 49 involved 36 individual pups.
We captured 233 different pups during 290 pup captures, but not all were CPVantibody tested. Pups comprised 8-70% of the wolves captured each year. Radiotagged wolves inhabited 4-10 (mean56.8) packs of 2-15 wolves per year (Mech, 1986, and unpublished data) .
Five of nine wolves captured in 1973 tested positive for CPV (titer5256) and five of 11 in 1974 (titers5256-2,048). The earliest CPV-positive wolf, and the first animal of any species anywhere docu- Table 3 ). Of 350 males tested, 183 (52%) were positive and 167 were negative. Of the 370 females, 201 (49%) were positive and 169 were negative; prevalence differences between genders were not statistically significant. Fifty-four (25%) pups tested positive and 165 negative versus 330 adults positive and 171 adults negative, a significant difference between adults and pups (P,0.01; X 2 5103.98, df51). For both adults and pups, almost equal proportions of males and females were positive.
CPV-antibody prevalence (adults and pups) increased in this population through 2004 (Table 2) , with evidence of periodicity of 7.33 (SE50.3) yr and dwindling amplitude (Fig. 2) . Table 4 number of parameters in each of the nine models, the residual sum of squares, computed AIC c , DAIC c (models sorted by), Akaike model weights, and adjusted R 2 values. Four models (models 1, 2, 3, and 7) had DAIC C values ,4.0, with the remaining models offering less evidence of plausibility. Models 1, 2, and 3 indicated an increase in CPV with the latter two models accounting for the nonlinearity in the trajectory. The inclusion of model 7 in this set of plausible models provides evidence of periodicity. Some recaptured wolves seroconverted over short periods. Adult male 6041 had a titer of 128 on 6 September 1983 and 512 on 9 September; female pup 17 had a titer of 16 on August 7, 1987 and 1,024 on 19 August. The proportion of wolf recaptures converting from negative to positive or retaining their positive status increased with time (Fig. 3) . Of the 44 male and 54 female wolves tested 2-9 times over periods of up to 5.9 yr, 62% of the recaptures either seroconverted or remained positive, 29% remained negative, and one (9%) converted from positive to negative. Some wolves failed to seroconvert over long periods. Of the 83 male recaptures, six (7%) failed to seroconvert over periods of $1 year, including one after 1,753 days. Of the 92 female recaptures, eight (9%) failed to seroconvert over periods of $1 yr, including one after 2,139 days. However, all except one of these recaptured animals were tested before 1986. Six (14%) of the male and nine (17%) of the female recaptures converted from positive to negative and these cases were spread over the entire study period. One female and one male seroconverted from negative to positive and back to negative, and one female and one male converted from positive to negative and back to positive.
Nine (25%) of 36 wolves first caught and CPV tested as pups from 1975 to 1998 were positive on retest. Six (17%) of them retained positive status upon recapture 2 days to 3.1 yr later. Within 1 yr, nine (25%) had seroconverted, and by 4 yr, 50% had seroconverted.
The primary effect of CPV in the ISA wolf population could have been mortality of pups ,3 mo old (Eugster and Nairn, 1977; Meunier et al., 1981; Johnson et al., 1994) , as this would have removed them from our sample. Pups in our area are usually born about 25 April, and first appear outside the den 3 wk later. We were able to observe three CPV-positive (256-1,024) females (one during 2 yr) with litter sizes of four-six pups (mean 5.4 pups/litter). The earliest we caught a seropositive pup was on 13 July 1997.
However, this male pup weighed 15 kg, which is heavy for an 11-wk-old pup; the pup may have been born early. We radiocollared most pups .5-mo-old, so we were able to document their survival after that and often their cause of death. We documented the death of a 9-mo-old female from CPV infection (Mech et al., 1997) .
Pups 3-7 mo old comprised 0-70% of wolves live-trapped each year (Table 2) ; the proportion of pups in the total sample significantly declined curvilinearly throughout the study (r 2 50.33; P50.01) (Fig. 4) . The decline began in about 1984 after CPV became enzootic in the population (Mech and Goyal, 1995) 50.22; P50.03) and inversely related to CPV antibody prevalence (r 2 50.38; P,0.01). A related but more conservative (error-free) component of annual wolf population change, annual change in size of radio-tagged wolf packs, was also related to CPV antibody prevalence (r 2 50.35; P,0.01). 
The greater Minnesota wolf population
In the Minnesota wolf population at large, from 1979 through 2004, we captured 2,562 wolves in 16 counties and tested 221 for CPV antibodies from 1979 to 1989, and in 1991, 1992, and 2004 . Sixty-five percent were positive, significantly higher than the percent in the ISA (X 2 59.38; P,0.01; df51). Annual CPV antibody prevalence increased with time from 17% to 100% in 2004 (r 2 50.24; P50.13). CPV-antibody prevalence in eight counties varied from 33% to 85% with samples of six to 39 wolves per county. Three contiguous counties in extreme northwestern Minnesota had the highest antibody prevalence (69%, 75%, and 85%). Beltrami County had a significantly higher antibody prevalence than all other counties (X 2 54.06-11.49; P50.04-0.01; df51) with the exception of two neighboring counties; Lake of the Woods and Roseau Counties (Fig. 1) .
Twenty-four percent (n5668) of the wolves captured in greater Minnesota were pups (range 5-67%/year). The percent of pups captured each year declined (r 2 50.46; P,0.01) curvilinearly (Fig. 5) . The mean proportion of pups captured from 1979 through 1984 was 40, whereas from 1985 through 2004 it was 21 (P50.01). The Minnesota wolf population increased at an average annual rate of 3.0-4.5% from 1979 to 2004 (Fuller et al., 1992; Berg and Benson, 1999; Erb and Benson, 2004) .
History of CPV
One of the earliest locations where CPV appeared (the earliest on record) was in our northeastern Minnesota ISA. The area where we captured the first antibodypositive wolves is wilderness, but it contains gravel roads and canoe routes and is frequented by humans and dogs. The CPV status of wolves before 1973 is not known. We sampled only two wolves in 1972, neither of which was positive, although one had an antibody titer of 128, which some consider positive (Carmichael and Binn, 1981 In any case, in adult ISA wolves, CPVantibody prevalence increased (r 2 50.47; P,0.01) and from 1985 through 2004, it averaged 81%. In 3-7-mo-old ISA pups, however, CPV seroprevalence averaged 43% from 1973 through 1982 (n572), but as increasingly fewer pups survived and entered our sample (Fig. 4) , CPV seroprevalence in pups dropped to 12% from 1983 through 2004 (n5119; X 2 524.39; P,0.01, df51).
DISCUSSION
The apparent cyclicity and dwindling amplitude of CPV-antibody prevalence in our ISA appears to be a unique observation for a long study of a wildlife disease. In a 14-yr study of canine distemper in raccoons (Procyon lotor), epizootics occurred at 4-yr intervals but incidence did not vary during these events (Roscoe, 1993) . The Akaike weight model 7 is not strong compared to models 1, 2, and 3, but the adjusted R 2 value indicates a good fit to the trajectory (Table 4) . Although the evidence is not overwhelming, model 7 indicates a periodicity of 7.33 (SE50.32) yr (Table 5) . We note that model 7 includes structure that accounts for not only the period parameter P but also for the dampening of the fluctuation in the trajectory.
As CPV was infecting wolves in our ISA (Mech et al., 1986) , it also began to be detected elsewhere. CPV-antibody-positive dogs were documented in Greece in 1974 (Koptopoulos et al., 1986) , in the Netherlands in 1976 (Schwers et al., 1979) , and in Texas in 1977 (Eugster and Nairn, 1977) . In 1979, one of the three wolves sampled in Koochiching County in the main Minnesota population was positive (titer51,024), some 160 km west of our ISA, and in 1980, antibody prevalence in 19 wolves was 53%, with positive animals in Roseau County in northwestern Minnesota 275 km from our ISA.
CPV effect on wolves
We believe that the primary effect of CPV in our study is mortality in young pups. The only other way of explaining a 3171 (6.6814, 7.9786) link between increased CPV-antibody prevalence and decreased number of pups would be through a CPV effect on litter size of CPV-positive adult females. However, the mean litter size of our CPVpositive females (5.4 pups) compares favorably with the normal litter size of 6.0 (Mech, 1970) . Although about 10% of the wolves we captured and followed in our ISA had CPV titers $2,048, only one (9 mo old) wolf died from CPV. In beagles, CPV titers reached $1,280 only in individuals within 2 wk of active infection (Hirasawa et al., 1987) . Apparently most of our wolves $3 mo old were able to survive infections. Mortality related to CPV primarily occurs in 1-12-wk-old animals (Eugster and Nairn, 1977; Meunier et al., 1981; Johnson et al., 1994) , although CPV mortality has been reported in 15-mo-old captive wolves . Maternal antibodies in coyotes (Canis latrans) have been reported in 83% of pups of antibody-positive mothers and can persist for up to 8 wk (Green et al., 1984) . Titers of maternally derived antibodies in dog pups in large litters were lower than in small litters (Pollock and Carmichael, 1982) , but after 8-12 wk such pups were no longer protected (Meunier et al., 1981) . In coyote pups, the half life of maternally derived CPV antibody was 6.7 days (Green et al., 1984) and in dogs, 9.7 days (Pollock and Carmichael, 1982) . Thus wolf pups, without maternal antibodies, would become vulnerable to CPV when they emerge from the den at about 3 wk of age; pups with maternal antibodies would become susceptible after 6-8 wk.
Canine parvovirus may be maintained in the ISA wolf population by carrier animals. A dog with an HI titer of 4 at 6 mo postinfection, shed virus in feces for $6 mo (Komolafe, 1985) ; CPV can remain infective in feces $7 mo (Gordon and Angrick, 1986) . It is possible that the virus can remain infective in wolf feces for #5 yr (Muneer et al., 1988) . Antibodies in dogs persisted $2 yr (Carmichael and Binn, 1981) . One of our wolves (female 5176) had positive titers all five times tested from 1975 through 1983. Our recapture data indicated that seroconversion can take place within 3-12 days and 25% of recaptured pups had seroconverted within a year.
Because wolf pups remain close to dens until $12 wk old (about July 25), our sampling technique, which depended on animals traveling, included few pups that were vulnerable to CPV. Therefore, the proportion of pups in our capture sample became an inverse index to pup survival. This index (i.e., pup survival) declined in our ISA (Mech et al., 1986) , especially after CPV became enzootic in the ISA about 1984 (Mech and Goyal, 1995) . An additional 11 yr of data from the ISA and an examination of this pup index in the wolf population at large now indicate that CPV has affected not only the local wolf population in the ISA, but also the entire Minnesota wolf population. The number of pups now surviving through summer each year has been reduced from the pre-CPV period by about 70% in the ISA and by 40-60% in the entire Minnesota wolf population. Although this drastic decline in pup survival does influence annual population change, as documented above in our ISA, enough pups still survive to maintain the population. This is because competition for food is keen in this saturated population, and pup starvation (Van Ballenberghe and Mech, 1975) and other types of mortality are high (Mech, 1977) . Thus, much of CPV-caused mortality merely compensates for other causes of death (Mech and Goyal, 1995) .
Population effects of CPV
In a population with the potential to colonize additional areas, the 40-60% pup reduction can seriously retard further colonization. A high proportion of surviving pups disperse from their natal packs when 1-3 yr old (Mech and Boitani, 2003) , seek new areas with adequate prey, mate, reproduce, and form new packs, thus expanding the population. The main prey of wolves in most of Minnesota is white-tailed deer, and although in low density in the ISA, they abound in most of Minnesota. There, the pre-CPV level of pup production would have led to increased dispersal and colonization of new areas similar to adjacent Wisconsin and Michigan, where wolves are increasing at many times Minnesota's rate (Fuller et al., 1992; Wydeven et al., 1995) . Although the growth of the Wisconsin wolf population apparently was retarded by CPV early in its recolonization (Wydeven et al., 1995) , it has since flourished. From 1981 through 1986, the nascent Wisconsin wolf population dropped from 21 to 16 individuals when its CPV antibody prevalence was 77% (24/31) whereas from 1988 to 1996 it increased an average of 18% per year from 26 to 99 wolves when CPV seroprevalence was down to 35% (22/63) (X 2 515.02; P50.01; df51; Wisconsin Department of Natural Resources, 1999) .
The known effects of CPV on young pups, our data on litter sizes, as well as our correlations and the lack of other plausible explanations, suggest that CPV caused the demographic changes we observed. In 2004, CPV antibody prevalence in greater Minnesota was 100% (n517), and from 1997 through 2004 antibody prevalence in ISA adults averaged 87% (72 of 83 animals).
A recent report that CPV antibody prevalence in Yellowstone National Park (YNP) wolves was 100% from 1995 to 2005 (Smith and Almberg, 2007) raises the question of why the CPV antibody prevalence in our area has fluctuated. One explanation is that the YNP wolves are highly isolated from any possible source of non-exposed immigrants. The ISA, conversely, adjoins the entire Canadian wolf population, so it receives immigration from pristine wilderness areas where CPV may not yet have become established. Wolves can disperse straight-line distances of up to 1,092 km (Wabakken et al., 2007) .
We still do not understand, however, what determines the spatial variation in CPV antibody prevalence in Minnesota wolves. While CPV was spreading through Minnesota, the prevalence was the highest in the extreme northwest. That area receives less precipitation, mostly ,60 cm/yr, whereas most of the rest of Minnesota wolf range receives 66-81 cm/ yr (Spatial Climate Analysis Service, 2000) . Transmission can occur through contact with infected feces, and dry feces can remain positive for CPV for more than 5 yr (Muneer et al., 1988) . Higher precipitation would serve to remove fecal material; the lower precipitation in northwestern Minnesota may explain the higher CPV antibody prevalence there. A higher precipitation of 76-86 cm/yr in Wisconsin's wolf range (Spatial Climate Analysis Service, 2000) also may explain why CPV is more sporadic there and has not become endemic in the wolf population. One final question our study raises involves the origin of CPV. Although much is known about the molecular changes that allowed the feline panleukopenia-like virus to spread to canids (Shackleton et al., 2005) , it is not known where and when that mutation occurred. The initial evidence of this virus in canids, specifically from wolves in northeastern Minnesota in 1973, supports the idea that wild canids may have been involved in this adaptation.
This study appears to be the first to document compelling, circumstantial evidence for long-term effects of CPV on a wildlife population and the only investigation that has followed the course of any wildlife disease from near its inception through its first 30 yr. We conclude, from our ISA data, from the greater Minnesota data, and from the Wisconsin data, that there is compelling circumstantial evidence that CPV may be a major determinant of rate of wolf population increase and recolonization over its current range in the midwestern USA and that it is restricting further recolonization of Minnesota.
